D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
VERV holding history
Verve Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VERV overviewAll 13F holders of VERVFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −10,586−100.0% | Sold out | Holders |
| Q2 2025 | 10,586 | $118.9K | <0.1% | −46,518−81.5% | Reduced | Holders |
| Q1 2025 | 57,104 | $261.0K | <0.1% | +19,120+50.3% | Added | Holders |
| Q4 2024 | 37,984 | $214.2K | <0.1% | +37,984 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −310,205−100.0% | Sold out | Holders |
| Q1 2024 | 310,205 | $4.12M | <0.1% | +88,158+39.7% | Added | Holders |
| Q4 2023 | 222,047 | $3.10M | <0.1% | +222,047 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −7,062−100.0% | Sold out | Holders |
| Q3 2022 | 7,062 | $243.0K | <0.1% | −87,063−92.5% | Reduced | Holders |
| Q2 2022 | 94,125 | $1.44M | <0.1% | +3,119+3.4% | Added | Holders |
| Q1 2022 | 91,006 | $2.08M | <0.1% | +78,380+620.8% | Added | Holders |
| Q4 2021 | 12,626 | $466.0K | <0.1% | −88,840−87.6% | Reduced | Holders |
| Q3 2021 | 101,466 | $4.77M | <0.1% | +43,647+75.5% | Added | Holders |
| Q2 2021 | 57,819 | $3.48M | <0.1% | +57,819 | New | Holders |